Principal Street Partners LLC Makes New $253,000 Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Principal Street Partners LLC acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 484 shares of the medical equipment provider's stock, valued at approximately $253,000.

A number of other large investors have also added to or reduced their stakes in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Intuitive Surgical by 12.8% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,826,972 shares of the medical equipment provider's stock worth $1,475,566,000 after purchasing an additional 319,694 shares during the period. Worldquant Millennium Advisors LLC purchased a new position in Intuitive Surgical during the 4th quarter valued at $1,775,000. Waverly Advisors LLC boosted its holdings in Intuitive Surgical by 21.2% during the 4th quarter. Waverly Advisors LLC now owns 11,799 shares of the medical equipment provider's stock valued at $6,159,000 after acquiring an additional 2,064 shares during the period. Williams Jones Wealth Management LLC. boosted its holdings in Intuitive Surgical by 4.9% during the 4th quarter. Williams Jones Wealth Management LLC. now owns 179,143 shares of the medical equipment provider's stock valued at $93,505,000 after acquiring an additional 8,447 shares during the period. Finally, Woodline Partners LP boosted its holdings in Intuitive Surgical by 27.0% during the 4th quarter. Woodline Partners LP now owns 82,889 shares of the medical equipment provider's stock valued at $43,265,000 after acquiring an additional 17,640 shares during the period. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Trading Down 0.6%

Shares of ISRG stock traded down $3.13 during mid-day trading on Friday, reaching $539.54. The stock had a trading volume of 1,138,538 shares, compared to its average volume of 1,644,578. The business's fifty day moving average is $511.55 and its 200-day moving average is $537.84. The firm has a market cap of $193.38 billion, a price-to-earnings ratio of 84.17, a PEG ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 1-year low of $396.15 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period in the prior year, the company earned $1.50 earnings per share. On average, analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Truist Financial dropped their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Robert W. Baird dropped their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. CICC Research began coverage on Intuitive Surgical in a report on Monday, January 27th. They issued a "neutral" rating and a $550.00 target price for the company. Piper Sandler lowered their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a report on Wednesday, April 23rd. Finally, Royal Bank of Canada lowered their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and a consensus target price of $596.05.

Insider Buying and Selling

In other Intuitive Surgical news, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the transaction, the director now owns 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of the firm's stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. This trade represents a 60.72% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 32,700 shares of company stock valued at $16,865,621 over the last ninety days. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.